Mainak Bardhan, Doctoral Researcher at Howard Hughes Medical Institute-University of Miami Miller School of Medicine, shared Jason Binder’s, Founder & CEO of Ember, post on LinkedIn, adding:
“It has been an exciting learning experience working with and learning from Daniel Pomeranz Krummel, on the role of ex vivo platforms in drug discovery for Glioblastoma, while writing our article in the special collection of Artificial Intelligence in Neuro-oncology in Journal of Neuro-oncology led by Prof Soma Sengupta, Dr Sonikpreet Aulakh, and Dr Akanksha Sharma.”
Title: Integrating ex vivo platforms with AI to guide glioblastoma treatment
Authors: Mainak Bardhan, Samanta Paul, Sirjana Pun, Manish Raj Aryal, Pier Paolo Claudio, Jason Binder, Riccardo Barrile, Daniel A. Pomeranz Krummel.
Quoting Jason Binder’s post:
“I am overjoyed to share that our paper was published today in the Journal of Neuro-Oncology.
The timing is deeply personal. Today is my wedding anniversary! What a gift from Tracy.
I’m grateful to the scientific experts who invited me to contribute the patient and caregiver perspective, and who recognized the work we are building at Ember as part of this conversation.
The paper speaks directly to the burden families carry while navigating molecular testing, treatment decisions, uncertainty, and rapidly changing circumstances.
To every family going through glioblastoma right now, this work is for you.
And to my coauthors, thank you for making room for the lived experience alongside the science.”
You can also read: NCI Glioblastoma Therapeutics Network U19 Grant 20
